title: Relationship between paraoxonase-1 activity, its Q192R genetic variant and clopidogrel responsiveness in the ADRIE study.
authors.forename: P
authors.initials: P
authors.lastname: Fontana
authors.forename: R
authors.initials: R
authors.lastname: James
authors.forename: I
authors.initials: I
authors.lastname: Barazer
authors.forename: P
authors.initials: P
authors.lastname: Berdagué
authors.forename: J-F
authors.initials: JF
authors.lastname: Schved
authors.forename: M
authors.initials: M
authors.lastname: Rebsamen
authors.forename: N
authors.initials: N
authors.lastname: Vuilleumier
authors.forename: J-L
authors.initials: JL
authors.lastname: Reny
mesh_terms: D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics / Q000378:metabolism; D043303:Aryldialkylphosphatase / Q000235:genetics* / Q000378:metabolism; D000077144:Clopidogrel; D065731:Cytochrome P-450 CYP2C19; D004351:Drug Resistance / Q000235:genetics; D014644:Genetic Variation; D005838:Genotype; D006801:Humans; D017202:Myocardial Ischemia / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics; D010641:Phenotype; D010974:Platelet Aggregation / Q000187:drug effects* / Q000235:genetics; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D010979:Platelet Function Tests; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19; D043303:Aryldialkylphosphatase; C468406:PON1 protein, human; D013988:Ticlopidine